These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 16273749)

  • 1. [Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
    Rossini R; Lucà MG; Scuri P; Invernizzi P; Strazzabosco M; Gavazzi A
    Ital Heart J Suppl; 2005 Oct; 6(10):621-6. PubMed ID: 16273749
    [No Abstract]   [Full Text] [Related]  

  • 2. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].
    Morini S; Zullo A
    G Ital Cardiol (Rome); 2010 Jun; 11(6):488-92; discussion 492. PubMed ID: 20922875
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents.
    Kang JM; Kim N; Lee BH; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
    Scand J Gastroenterol; 2011 Nov; 46(11):1295-301. PubMed ID: 21815866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin and gastrointestinal toxicity.
    Törüner M
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():27-30. PubMed ID: 18160364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gastrointestinal bleeding during low dose acetylsalicylic acid. Is Godamed-100 TAH an alternative to conventional ASS preparations?].
    Maywald U; Schindler C
    Dtsch Med Wochenschr; 2005 Apr; 130(16):1026-7. PubMed ID: 15830316
    [No Abstract]   [Full Text] [Related]  

  • 7. Upper GI risks of NSAIDs and antiplatelet agents: key issues for the cardiologist.
    Johnson DA
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S15-22. PubMed ID: 17710072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori and nonsteroidal anti-inflammatory drug interactions in bleeding ulcers.
    Radaelli F; Minoli G
    Gastrointest Endosc; 2002 Oct; 56(4):604-6; discussion 606-7. PubMed ID: 12375565
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pathogen eradication prevents gastrointestinal complications].
    MMW Fortschr Med; 2007 Oct; 149(43):58-9. PubMed ID: 17992910
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gastric protection and treatment with low-dose aspirin].
    Agustí-Escasany A; Vallano-Ferraz A
    Med Clin (Barc); 2006 Feb; 126(6):232-3. PubMed ID: 16510098
    [No Abstract]   [Full Text] [Related]  

  • 11. Reducing the risks of gastrointestinal bleeding with antiplatelet therapies.
    Cryer B
    N Engl J Med; 2005 Jan; 352(3):287-9. PubMed ID: 15659730
    [No Abstract]   [Full Text] [Related]  

  • 12. Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding.
    McKeogh DF
    N Engl J Med; 2003 Jun; 348(24):2464-6; author reply 2464-6. PubMed ID: 12803214
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of Helicobacter pylori positivity in patients undergoing percutaneous coronary intervention.
    Hiew C; Duggan A; de Malmanche T; Hatton R; Baker F; Attia J; Collins N
    Intern Med J; 2012 Mar; 42(3):289-93. PubMed ID: 20492005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
    Hsu PI
    J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summaries for patients. Benefits and risks of continuing aspirin in patients with peptic ulcer bleeding.
    Ann Intern Med; 2010 Jan; 152(1):I-20. PubMed ID: 19949137
    [No Abstract]   [Full Text] [Related]  

  • 16. [Risk of gastrointestinal bleeding with aspirin and platelet antiaggregants].
    Nardulli G; Lanas A
    Gastroenterol Hepatol; 2009 Jan; 32(1):36-43. PubMed ID: 19174098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting poor outcome from acute upper gastrointestinal hemorrhage.
    Chiu PW; Ng EK
    Gastroenterol Clin North Am; 2009 Jun; 38(2):215-30. PubMed ID: 19446255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors.
    Venerito M; Schneider C; Costanzo R; Breja R; Röhl FW; Malfertheiner P
    Aliment Pharmacol Ther; 2018 Jun; 47(11):1464-1471. PubMed ID: 29655196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs.
    Nakashima S; Arai S; Mizuno Y; Yoshino K; Ando S; Nakamura Y; Sugawara K; Koike M; Saito E; Naito M; Nakao M; Ito H; Hamaoka K; Rai F; Asakura Y; Akamatu M; Fujimori K; Inao M; Imai Y; Ota S; Fujiwara K; Shiibashi M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():60-6. PubMed ID: 15943849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastrointestinal complications of nonsteroidal anti-inflammatory drugs and low-dose aspirin].
    Thiéfin G
    Gastroenterol Clin Biol; 2003 May; 27(5):498-510. PubMed ID: 12843912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.